Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: a randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON).

N. Thielen; B. van der Holt; J.J. Cornelissen; G.E.G. Verhoef; T. Gussinklo; B.J. Biemond; S.M.G. Daenen; W. Deenik; M. van Marwijk Kooy; E.J. Petersen; W.M Smit; P.J.M. Valk; G.J. Ossenkoppele; J.J.W.M. Janssen

Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: a randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON).

N. Thielen
, B. van der Holt
, J.J. Cornelissen
, G.E.G. Verhoef
, T. Gussinklo
, B.J. Biemond
, S.M.G. Daenen
, W. Deenik
, M. van Marwijk Kooy
, E.J. Petersen
, W.M Smit
, P.J.M. Valk
, G.J. Ossenkoppele
, J.J.W.M. Janssen

Hematology/Van Creveldclinic

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	3242-3246
Number of pages	5
Journal	European Journal of Cancer
Volume	49
Issue number	15
Publication status	Published - 2013

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/23876833

Cite this

Thielen, N., van der Holt, B., Cornelissen, J. J., Verhoef, G. E. G., Gussinklo, T., Biemond, B. J., Daenen, S. M. G., Deenik, W., van Marwijk Kooy, M., Petersen, E. J., Smit, W. M., Valk, P. J. M., Ossenkoppele, G. J., & Janssen, J. J. W. M. (2013). Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: a randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON). European Journal of Cancer, 49(15), 3242-3246. http://www.ncbi.nlm.nih.gov/pubmed/23876833

@article{760a952b60d2482e93303da90f0f377a,

title = "Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: a randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON).",

author = "N. Thielen and \{van der Holt\}, B. and J.J. Cornelissen and G.E.G. Verhoef and T. Gussinklo and B.J. Biemond and S.M.G. Daenen and W. Deenik and \{van Marwijk Kooy\}, M. and E.J. Petersen and W.M Smit and P.J.M. Valk and G.J. Ossenkoppele and J.J.W.M. Janssen",

year = "2013",

language = "English",

volume = "49",

pages = "3242--3246",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

number = "15",

}

Thielen, N, van der Holt, B, Cornelissen, JJ, Verhoef, GEG, Gussinklo, T, Biemond, BJ, Daenen, SMG, Deenik, W, van Marwijk Kooy, M, Petersen, EJ, Smit, WM, Valk, PJM, Ossenkoppele, GJ & Janssen, JJWM 2013, 'Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: a randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON).', European Journal of Cancer, vol. 49, no. 15, pp. 3242-3246. <http://www.ncbi.nlm.nih.gov/pubmed/23876833>

Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: a randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON). / Thielen, N.; van der Holt, B.; Cornelissen, J.J. et al.
In: European Journal of Cancer, Vol. 49, No. 15, 2013, p. 3242-3246.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: a randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON).

AU - Thielen, N.

AU - van der Holt, B.

AU - Cornelissen, J.J.

AU - Verhoef, G.E.G.

AU - Gussinklo, T.

AU - Biemond, B.J.

AU - Daenen, S.M.G.

AU - Deenik, W.

AU - van Marwijk Kooy, M.

AU - Petersen, E.J.

AU - Smit, W.M

AU - Valk, P.J.M.

AU - Ossenkoppele, G.J.

AU - Janssen, J.J.W.M.

PY - 2013

Y1 - 2013

M3 - Article

SN - 0959-8049

VL - 49

SP - 3242

EP - 3246

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 15

ER -